Monte Rosa Therapeutics, Inc. (GLUE) SEC filings
GLUENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3041% above fair value
$9.07−0.09 (-0.98%)
Close on Nov 17, 2026Market cap $773.79MP/E –Yield –
SEC filings
40 of Monte Rosa Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 5, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2026 | Nov 5, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2026 | Oct 1, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2026 | Sep 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 29, 2026 | Apr 29, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 17, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2026 | Mar 17, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 9, 2026 | Feb 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2026 | Jan 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2026 | Jan 7, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2026 | Jan 7, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2025 | Dec 16, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2025 | Sep 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2025 | Jun 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 25, 2025 | Apr 25, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 20, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 20, 2025 | Mar 20, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 10, 2025 | Jan 10, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2024 | Dec 13, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 5, 2024 | Dec 5, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 25, 2024 | Oct 28, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 27, 2024 | Jun 27, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2024 | Jun 12, 2024 | SEC EDGAR |
| Current report | 8-K | May 28, 2024 | May 30, 2024 | SEC EDGAR |
| Current report | 8-K | May 15, 2024 | May 16, 2024 | SEC EDGAR |
See a number that looks wrong?